Literature DB >> 17327217

Reproductive history and cutaneous malignant melanoma: a comparison between women and men.

Jeanette Kaae1, Andreas Andersen, Heather A Boyd, Jan Wohlfahrt, Mads Melbye.   

Abstract

To evaluate whether previously observed associations between parity and cutaneous malignant melanoma (CMM) risk in women reflected a biologic mechanism or resulted from uncontrolled confounding by lifestyle factors associated with parity (e.g., patterns of sun exposure), the authors investigated the effect of reproductive history (parenthood) on CMM risk in both women and men. Using information from Danish national registers (1968-2003), the authors established a population-based cohort of more than 3,500,000 persons with information on parenthood and CMM. Relative risks were estimated using Poisson regression models. Overall, number of children was significantly associated with a woman's risk of CMM (p = 0.004), with the lowest risk being seen among women with many births. Women aged 25 years or older at their first birth had a 24% (95% confidence interval: 16, 33) higher risk of CMM than younger women. Ten or more years after the birth of her youngest child, a woman had a 15% (95% confidence interval: 5, 27) higher risk of CMM than she did in the first 10 years. Similar results were observed in men. The similarity of effects for men and women suggests that lifestyle factors, rather than exposure to pregnancy hormones, may be responsible for the observed associations between reproductive history and CMM risk in women.

Entities:  

Mesh:

Year:  2007        PMID: 17327217     DOI: 10.1093/aje/kwm015

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

Review 1.  [Melanoma and pregnancy].

Authors:  C Erfurt-Berge; E Kaempgen
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

2.  Age at first birth and melanoma risk: a meta-analysis.

Authors:  Zhengyong Li; Mingjin Gu; Ying Cen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.

Authors:  Jim Z Mai; Rui Zhang; Michael R Sargen; Mark P Little; Bruce H Alexander; Margaret A Tucker; Cari M Kitahara; Elizabeth K Cahoon
Journal:  Hum Reprod       Date:  2022-05-03       Impact factor: 6.353

4.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

Review 5.  Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.

Authors:  Federica Tomao; Anselmo Papa; Giuseppe Lo Russo; Sara Zuber; Gian Paolo Spinelli; Luigi Rossi; Davide Caruso; Natalie Prinzi; Valeria Stati; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-06-27

6.  The Family Life Course and Health: Partnership, Fertility Histories, and Later-Life Physical Health Trajectories in Australia.

Authors:  Martin O'Flaherty; Janeen Baxter; Michele Haynes; Gavin Turrell
Journal:  Demography       Date:  2016-06

7.  Effects of fertility drugs on cancers other than breast and gynecologic malignancies.

Authors:  Louise A Brinton; Kamran S Moghissi; Bert Scoccia; Emmet J Lamb; Britton Trabert; Shelley Niwa; David Ruggieri; Carolyn L Westhoff
Journal:  Fertil Steril       Date:  2015-07-29       Impact factor: 7.329

8.  Having children with multiple partners is associated with reduced risk of malignant melanoma: an observation seeking a plausible explanation.

Authors:  Anne V Olesen; Erik T Parner; Preben B Mortensen; Cecilia H Ramlau-Hansen; Jørn Olsen
Journal:  Clin Epidemiol       Date:  2010-10-21       Impact factor: 4.790

Review 9.  Streamlining cutaneous melanomas in young women of the Belgian Mosan region.

Authors:  Trinh Hermanns-Lê; Sébastien Piérard
Journal:  Biomed Res Int       Date:  2014-02-25       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.